Remove Documentation Remove Vaccines Remove White Paper
article thumbnail

Quality by design with a focus on biosimilars

Pharmaceutical Technology

QbD principles are woven into regulatory guidance documents, primarily guidances Q8 to Q11 of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). For more information on this, please download our white paper. For more information, please download our white paper.

article thumbnail

Coalition issues rallying cry to takes the fight against AMR to the front line

pharmaphorum

Unlike many of its predecessors, then, this document is not merely an exercise in raising awareness. BIVDA really hope that the white paper will help inform UK policy makers and give them areas to focus on which we, as a coalition, see as critical to start moving this issue forward.”. Clear objectives.

article thumbnail

The supply chain innovations behind the world’s largest vaccine programme

Pharmaceutical Technology

To develop a vaccine and then get as many people vaccinated as quickly as possible. Advanced monitoring and analysis technology has enabled more than 13 billion COVID-19 vaccinations to be distributed worldwide to date. Before the COVID-19 pandemic, 25-50% of vaccines were wasted due to cold chain issues.